Related references
Note: Only part of the references are listed.Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials
Andrew J. Armstrong et al.
JAMA ONCOLOGY (2020)
Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration -resistant prostate cancer y
S. Halabi et al.
ANNALS OF ONCOLOGY (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion
Yanyan Liu et al.
FASEB JOURNAL (2019)
Overall survival by race in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide.
Megan Ann McNamara et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T. Dess et al.
JAMA ONCOLOGY (2019)
Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase
Cheng-Fan Lee et al.
ONCOGENE (2019)
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer
Celestia S. Higano et al.
CANCER (2019)
Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data
Laura Clarke et al.
NUCLEIC ACIDS RESEARCH (2017)
Joint genotype- and ancestry-based genome-wide association studies in admixed populations
Piotr Szulc et al.
GENETIC EPIDEMIOLOGY (2017)
Sphingosine Kinase-1 Involves the Inhibitory Action of HIF-1 by Chlorogenic Acid in Hypoxic DU145 Cells
Myoung-Sun Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer
Sundhar Ramalingam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion
Yu Wang et al.
SCIENTIFIC REPORTS (2017)
Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR
Yuka Aoyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
SIFT missense predictions for genomes
Robert Vaser et al.
NATURE PROTOCOLS (2016)
Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer
Che-Kai Tsao et al.
ONCOLOGIST (2016)
Racial Differences in the Diagnosis and Treatment of Prostate Cancer
Giuliano Di Pietro et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2016)
Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer
Isabelle Ader et al.
ONCOTARGET (2015)
Coumestrol suppresses hypoxia inducible factor 1α by inhibiting ROS mediated sphingosine kinase 1 in hypoxic PC-3 prostate cancer cells
Sung-Yun Cho et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
An exploratory analysis of efficacy and safety of abiraterone acetate (AA) in black patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (ctx)
Eleni Efstathiou et al.
CANCER RESEARCH (2014)
Detecting Structure of Haplotypes and Local Ancestry
Yongtao Guan
GENETICS (2014)
Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells
Leyre Brizuela et al.
MOLECULAR ONCOLOGY (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection
J. Nunes et al.
BRITISH JOURNAL OF CANCER (2012)
First Evidence of Sphingosine 1-Phosphate Lyase Protein Expression and Activity Downregulation in Human Neoplasm: Implication for Resistance to Therapeutics in Prostate Cancer
Leyre Brizuela et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Adjustment for local ancestry in genetic association analysis of admixed populations
Xuexia Wang et al.
BIOINFORMATICS (2011)
Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells
Sung-Yun Cho et al.
JOURNAL OF PINEAL RESEARCH (2011)
FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
Dmitri Pchejetski et al.
CANCER RESEARCH (2010)
Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens
Bernard Malavaud et al.
EUROPEAN JOURNAL OF CANCER (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Integrating common and rare genetic variation in diverse human populations
David M. Altshuler et al.
NATURE (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel
Lysann Sauer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Sphingosine Kinase-1 Is Central to Androgen-Regulated Prostate Cancer Growth and Survival
Audrey Dayon et al.
PLOS ONE (2009)
Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1α during Hypoxia in Human Cancer Cells
Isabelle Ader et al.
CANCER RESEARCH (2008)
Pain predicts overall survival in men with metastatic castration-refractory prostate cancer
Susan Halabi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models
Dimitri Pchejetski et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Regional admixture mapping and structured association testing: Conceptual unification and an extensible general linear model
David T. Redden et al.
PLOS GENETICS (2006)
Clinical outcomes by age in men with hormone refractory prostate cancer: A pooled analysis of 8 cancer and leukemia group B (CALGB) studies
S Halabi et al.
JOURNAL OF UROLOGY (2006)
High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation
Y Akao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models
D Pchejetski et al.
CANCER RESEARCH (2005)
Impact of race on survival in men with metastatic hormone-refractory prostate cancer
S Halabi et al.
UROLOGY (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
